EU-AI-Act

2 observations filed under this label.

AI Drug Discovery's Moment of Truth: A $2.75B Bet, Zero Approvals, and the Drug That Could Change Both

Eli Lilly just wagered up to $2.75 billion on AI-designed medicines, yet not one AI-discovered drug has full FDA approval. Here's why 2026 is the year the field finally gets tested against clinical reality.

The EU AI Act's Big Deadline Just Passed — and Drug Discovery Got a Reprieve

August 2, 2026 was supposed to be the day the EU AI Act's toughest rules hit high-risk systems. Then the Digital Omnibus moved the goalposts. Here's what actually changed, and what it means for AI in drug discovery.